Literature DB >> 19095751

Anthropometry, CT, and DXA as predictors of GH deficiency in premenopausal women: ROC curve analysis.

Miriam A Bredella1, Andrea L Utz, Martin Torriani, Bijoy Thomas, David A Schoenfeld, Karen K Miller.   

Abstract

Visceral adiposity is a strong determinant of growth hormone (GH) secretion, and states of GH deficiency are associated with increased visceral adiposity and decreased lean body mass. The purpose of our study was to determine the sensitivity and specificity of different methods of assessing body composition [anthropometry, dual-energy X-ray absorptiometry (DXA), and computed tomography (CT)] to predict GH deficiency in premenopausal women and threshold values for each technique to predict GH deficiency, using receiver operator characteristic (ROC) curve analysis. We studied a group of 45 healthy lean, overweight, and obese premenopausal women who underwent anthropometric measurements (body mass index, waist and hip circumferences, skin fold thickness), DXA, CT, and a GH-releasing hormone-arginine stimulation test. ROC curve analysis was used to determine cutoff values for each method to identify GH deficiency. Visceral adiposity measured by CT showed the highest sensitivity and specificity for identifying subjects with GH deficiency with a cutoff of >9,962 mm(2) [area under the curve (AUC), 0.95; sensitivity, 100%; specificity, 77.8%; P = 0.0001]. Largest waist circumference showed high sensitivity and specificity with a cutoff of >101.7 cm (AUC, 0.89; sensitivity, 88.9%; specificity, 75%; P = 0.0001). When the ROC curves of visceral fat measured by CT and largest waist circumference were compared, the difference between the two methods was not statistically significant (P = 0.36). Our study showed that the largest waist circumference predicts the presence of GH deficiency in healthy premenopausal women with high sensitivity and specificity and nearly as well as CT measurement of visceral adiposity. It can be used to identify women in whom GH deficiency is likely and therefore in whom formal GH stimulation testing might be indicated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095751      PMCID: PMC2644238          DOI: 10.1152/japplphysiol.90998.2008

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  35 in total

1.  Effects of discontinuation of growth hormone treatment on body composition and metabolism.

Authors:  W J Gerver; R De Bruin; H A Delemarre v d Waal; B Aldewereld; P Theunissen; K R Westerterp
Journal:  Horm Res       Date:  2000

2.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

3.  Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality.

Authors:  B Nilsson; E Gustavasson-Kadaka; B A Bengtsson; B Jonsson
Journal:  J Clin Endocrinol Metab       Date:  2000-04       Impact factor: 5.958

Review 4.  Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.

Authors:  B L Wajchenberg
Journal:  Endocr Rev       Date:  2000-12       Impact factor: 19.871

5.  Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.

Authors:  Beverly M K Biller; Mary H Samuels; Anthony Zagar; David M Cook; Baha M Arafah; Vivien Bonert; Stavros Stavrou; David L Kleinberg; John J Chipman; Mark L Hartman
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

6.  Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors.

Authors:  J L Clasey; A Weltman; J Patrie; J Y Weltman; S Pezzoli; C Bouchard; M O Thorner; M L Hartman
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

7.  Misclassification of high-risk older subjects using waist action levels established for young and middle-aged adults--results from the Rotterdam Study.

Authors:  A Molarius; J C Seidell; T L Visscher; A Hofman
Journal:  J Am Geriatr Soc       Date:  2000-12       Impact factor: 5.562

8.  Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.

Authors:  S R Smith; J C Lovejoy; F Greenway; D Ryan; L deJonge; J de la Bretonne; J Volafova; G A Bray
Journal:  Metabolism       Date:  2001-04       Impact factor: 8.694

9.  The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry.

Authors:  M B Snijder; M Visser; J M Dekker; J C Seidell; T Fuerst; F Tylavsky; J Cauley; T Lang; M Nevitt; T B Harris
Journal:  Int J Obes Relat Metab Disord       Date:  2002-07

10.  Androgens may mediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion.

Authors:  A L Utz; A Yamamoto; P Sluss; J Breu; K K Miller
Journal:  J Clin Endocrinol Metab       Date:  2008-07-22       Impact factor: 5.958

View more
  8 in total

1.  Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.

Authors:  Miriam A Bredella; Eleanor Lin; Danielle J Brick; Anu V Gerweck; Lindsey M Harrington; Martin Torriani; Bijoy J Thomas; David A Schoenfeld; Anne Breggia; Clifford J Rosen; Linda C Hemphill; Zida Wu; Nader Rifai; Andrea L Utz; Karen K Miller
Journal:  Eur J Endocrinol       Date:  2012-01-24       Impact factor: 6.664

2.  Effects of growth hormone administration for 6 months on bone turnover and bone marrow fat in obese premenopausal women.

Authors:  Miriam A Bredella; Anu V Gerweck; Lauren A Barber; Anne Breggia; Clifford J Rosen; Martin Torriani; Karen K Miller
Journal:  Bone       Date:  2014-02-05       Impact factor: 4.398

3.  Determinants of bone mineral density in obese premenopausal women.

Authors:  Miriam A Bredella; Martin Torriani; Reza Hosseini Ghomi; Bijoy J Thomas; Danielle J Brick; Anu V Gerweck; Lindsey M Harrington; Anne Breggia; Clifford J Rosen; Karen K Miller
Journal:  Bone       Date:  2010-12-30       Impact factor: 4.398

4.  Impact of aerobic exercise training on heart rate variability and functional capacity in obese women after gastric bypass surgery.

Authors:  Viviane Castello; Rodrigo Polaquini Simões; Daniela Bassi; Aparecida Maria Catai; Ross Arena; Audrey Borghi-Silva
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

5.  In premenopausal women with idiopathic osteoporosis, lower bone formation rate is associated with higher body fat and higher IGF-1.

Authors:  T G Goetz; N Nair; S Shiau; R R Recker; J M Lappe; D W Dempster; H Zhou; B Zhao; X Guo; W Shen; T L Nickolas; M Kamanda-Kosseh; M Bucovsky; J Stubby; E Shane; A Cohen
Journal:  Osteoporos Int       Date:  2021-10-19       Impact factor: 4.507

6.  Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity.

Authors:  Miriam A Bredella; Martin Torriani; Bijoy J Thomas; Reza Hosseini Ghomi; Danielle J Brick; Anu V Gerweck; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2009-07-14       Impact factor: 5.958

7.  Assessment of abdominal fat compartments using DXA in premenopausal women from anorexia nervosa to morbid obesity.

Authors:  Miriam A Bredella; Corey M Gill; Leigh K Keating; Martin Torriani; Ellen J Anderson; Mark Punyanitya; Kevin E Wilson; Thomas L Kelly; Karen K Miller
Journal:  Obesity (Silver Spring)       Date:  2013-06-13       Impact factor: 5.002

8.  Potential Effects on Cardiorespiratory and Metabolic Status After a Concurrent Strength and Endurance Training Program in Diabetes Patients - a Randomized Controlled Trial.

Authors:  Daniela Bassi; Renata Gonçalves Mendes; Vivian Maria Arakelian; Flávia Cristina Rossi Caruso; Ramona Cabiddu; José Carlos Bonjorno Júnior; Ross Arena; Audrey Borghi-Silva
Journal:  Sports Med Open       Date:  2016-08-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.